<?xml version="1.0" encoding="UTF-8"?>
<record
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd"
    xmlns="http://www.loc.gov/MARC21/slim">

  <leader>02459cam a2200361 a 4500</leader>
  <datafield tag="060" ind1="0" ind2="0">
    <subfield code="a">WA 712</subfield>
    <subfield code="b">R644a 1990</subfield>
  </datafield>
  <datafield tag="070" ind1="0" ind2=" ">
    <subfield code="a">QP801.A84R63</subfield>
  </datafield>
  <datafield tag="072" ind1=" " ind2="0">
    <subfield code="a">T300</subfield>
  </datafield>
  <datafield tag="072" ind1=" " ind2="0">
    <subfield code="a">Q400</subfield>
  </datafield>
  <controlfield tag="001">ocm20594230 </controlfield>
  <controlfield tag="003">OCoLC</controlfield>
  <controlfield tag="005">20090804062048.0</controlfield>
  <controlfield tag="008">890901s1990    paua     b    001 0 eng  </controlfield>
  <datafield tag="010" ind1=" " ind2=" ">
    <subfield code="a">   89081086 </subfield>
  </datafield>
  <datafield tag="016" ind1="7" ind2=" ">
    <subfield code="a">9112544</subfield>
    <subfield code="2">DNLM</subfield>
  </datafield>
  <datafield tag="020" ind1=" " ind2=" ">
    <subfield code="a">0914783378</subfield>
  </datafield>
  <datafield tag="020" ind1=" " ind2=" ">
    <subfield code="a">9780914783374</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
    <subfield code="a">(OCoLC)20594230</subfield>
    <subfield code="z">(OCoLC)24505391</subfield>
  </datafield>
  <datafield tag="040" ind1=" " ind2=" ">
    <subfield code="a">DLC</subfield>
    <subfield code="c">DLC</subfield>
    <subfield code="d">AGL</subfield>
    <subfield code="d">VET</subfield>
    <subfield code="d">NLM</subfield>
    <subfield code="d">NOR</subfield>
    <subfield code="d">BAKER</subfield>
    <subfield code="d">BTCTA</subfield>
    <subfield code="d">YDXCP</subfield>
  </datafield>
  <datafield tag="050" ind1="0" ind2="0">
    <subfield code="a">QP801.A84</subfield>
    <subfield code="b">R63 1990</subfield>
  </datafield>
  <datafield tag="082" ind1="0" ind2="0">
    <subfield code="a">363.19/29</subfield>
    <subfield code="2">20</subfield>
  </datafield>
  <datafield tag="100" ind1="1" ind2=" ">
    <subfield code="a">Roberts, H. J.</subfield>
    <subfield code="q">(Hyman Jacob),</subfield>
    <subfield code="d">1924-</subfield>
  </datafield>
  <datafield tag="245" ind1="1" ind2="0">
    <subfield code="a">Aspartame (NutraSweet&#xFFFD;) :</subfield>
    <subfield code="b">is it safe? /</subfield>
    <subfield code="c">H.J. Roberts.</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="a">Philadelphia, PA :</subfield>
    <subfield code="b">Charles Press,</subfield>
    <subfield code="c">c1990.</subfield>
  </datafield>
  <datafield tag="300" ind1=" " ind2=" ">
    <subfield code="a">viii, 315 p. :</subfield>
    <subfield code="b">ill. ;</subfield>
    <subfield code="c">24 cm.</subfield>
  </datafield>
  <datafield tag="504" ind1=" " ind2=" ">
    <subfield code="a">Includes bibliographical references (p. 289-307) and index.</subfield>
  </datafield>
  <datafield tag="505" ind1="0" ind2="0">
    <subfield code="g">1. The</subfield>
    <subfield code="t">aspartame boom --</subfield>
    <subfield code="g">2.</subfield>
    <subfield code="t">How I became involved in the aspartame issue --</subfield>
    <subfield code="g">3.</subfield>
    <subfield code="t">Aspartame consumption --</subfield>
    <subfield code="g">4.</subfield>
    <subfield code="t">Aspartame metabolism --</subfield>
    <subfield code="g">5.</subfield>
    <subfield code="t">Excessive intake of phenylalanine and aspartic acid --</subfield>
    <subfield code="g">6.</subfield>
    <subfield code="t">Methyl alcohol --</subfield>
    <subfield code="g">7. A</subfield>
    <subfield code="t">clinical overview --</subfield>
    <subfield code="g">8.</subfield>
    <subfield code="t">General aspects of aspartame reactions --</subfield>
    <subfield code="g">9.</subfield>
    <subfield code="t">Convulsions (epilepsy) --</subfield>
    <subfield code="g">10.</subfield>
    <subfield code="t">Headache --</subfield>
    <subfield code="g">11.</subfield>
    <subfield code="t">Confusion and memory loss, intellectual deterioration --</subfield>
    <subfield code="g">12.</subfield>
    <subfield code="t">Other neurologic reactions --</subfield>
    <subfield code="g">13.</subfield>
    <subfield code="t">Psychiatric and behavioral reactions --</subfield>
    <subfield code="g">14.</subfield>
    <subfield code="t">Eye complaints --</subfield>
    <subfield code="g">15.</subfield>
    <subfield code="t">Ear complaints --</subfield>
    <subfield code="g">16.</subfield>
    <subfield code="t">Excessive weight loss : anorexia and bulimia --</subfield>
    <subfield code="g">17.</subfield>
    <subfield code="t">Paradoxical weight gain --</subfield>
    <subfield code="g">18.</subfield>
    <subfield code="t">Allergic reactions --</subfield>
    <subfield code="g">19.</subfield>
    <subfield code="t">Gastrointestinal problems --</subfield>
    <subfield code="g">20.</subfield>
    <subfield code="t">Heart and chest problems --</subfield>
    <subfield code="g">21.</subfield>
    <subfield code="t">Other reactions --</subfield>
    <subfield code="g">22.</subfield>
    <subfield code="t">Drug interactions --</subfield>
    <subfield code="g">23.</subfield>
    <subfield code="t">Pregnant women, nursing mothers --</subfield>
    <subfield code="t">24.</subfield>
    <subfield code="t">Infants and children --</subfield>
    <subfield code="g">25.</subfield>
    <subfield code="t">Diabetes --</subfield>
    <subfield code="g">26.</subfield>
    <subfield code="t">Patients prone to hypoglycemia --</subfield>
    <subfield code="g">27.</subfield>
    <subfield code="t">Alcoholism --</subfield>
    <subfield code="g">28. The</subfield>
    <subfield code="t">elderly (is there an aspartame-alzheimer connection?) --</subfield>
    <subfield code="g">29.</subfield>
    <subfield code="t">Patients with phenylketonuria (PKU) and PKU carriers --</subfield>
    <subfield code="g">30.</subfield>
    <subfield code="t">Does aspartame pose an imminent public health hazard --</subfield>
    <subfield code="g">31.</subfield>
    <subfield code="t">Public health issues --</subfield>
    <subfield code="g">32. The</subfield>
    <subfield code="t">myth of "The most thoroughly tested additive in history" --</subfield>
    <subfield code="g">33.</subfield>
    <subfield code="t">Attitudes of consumers and patients --</subfield>
    <subfield code="g">34.</subfield>
    <subfield code="t">consumer advocates and aspartame --</subfield>
    <subfield code="g">35.</subfield>
    <subfield code="t">Alternatives to aspartame.</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="0">
    <subfield code="a">Aspartame</subfield>
    <subfield code="x">Physiological effect.</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="0">
    <subfield code="a">Aspartame</subfield>
    <subfield code="x">Health aspects.</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="2">
    <subfield code="a">Aspartame</subfield>
    <subfield code="x">adverse effects.</subfield>
  </datafield>
  <datafield tag="942" ind1=" " ind2=" ">
    <subfield code="2">ddc</subfield>
    <subfield code="c">BK</subfield>
  </datafield>
  <datafield tag="948" ind1=" " ind2=" ">
    <subfield code="h">NO HOLDINGS IN ZAAPA - 802 OTHER HOLDINGS</subfield>
  </datafield>
  <datafield tag="999" ind1=" " ind2=" ">
    <subfield code="c">4949</subfield>
    <subfield code="d">4949</subfield>
  </datafield>
</record>
